EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.1.1.14 | Acidosis |
8064656 |
Hyperlipemia and ketonuria in an alpaca and a llama. |
causal interaction unassigned |
3 0 |
1.1.1.14 | Acquired Immunodeficiency Syndrome |
10499817 |
Modern diets and diseases: NO-zinc balance. Under Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and cancer. |
causal interaction therapeutic application unassigned |
1 1 0 |
1.1.1.14 | Adenoviridae Infections |
11090175 |
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. |
causal interaction diagnostic usage unassigned |
1 2 0 |
1.1.1.14 | Albuminuria |
14968292 |
Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency. |
ongoing research unassigned |
2 0 |
1.1.1.14 | Anemia |
2019341 |
Prechronic inhalation toxicity studies of 2-mercaptobenzimidazole (2-MBI) in F344/N rats. |
unassigned |
0 |
1.1.1.14 | Anemia |
7147611 |
Heinz body anemia and methemoglobinemia in ponies given red maple (acer rubrum L.) leaves. |
unassigned |
0 |
1.1.1.14 | Anemia |
12579206 |
NTP Toxicology and Carcinogenesis Studies of Chloroprene (CAS No. 126-99-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). |
diagnostic usage unassigned |
1 0 |
1.1.1.14 | Anemia |
14021262 |
[Changes in serum and liver sorbitol dehydrogenase during experimentally induced immunohemolytic anemia.] |
ongoing research unassigned |
2 0 |
1.1.1.14 | Anemia |
15954549 |
Acute hemoperitoneum in horses: a review of 19 cases (1992-2003). |
causal interaction diagnostic usage unassigned |
2 3 0 |
1.1.1.14 | Atherosclerosis |
16892577 |
[Effect of sodium fluoride on the activity of sorbitol dehydrogenase in plasma and liver of rabbits with experimental atherosclerosis] |
ongoing research therapeutic application unassigned |
4 1 0 |